By: Jakob Siedlecki
A case highlighting the role for SMILE® to provide monovision and spectacle independence as an effective and safe treatment for a presbyopic ametropic patient.
Download Now
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.